查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1620815

大鼠和小鼠模型市场：按模型类型、技术、服务、治疗领域和最终用户划分 - 2025-2030 年全球预测

Rat & Mouse Model Market by Model Type, Technology, Service, Therapeutic Area, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年大鼠和小鼠模型市场的市场规模为22.7亿美元，预计2024年将达到24.5亿美元，复合年增长率为8.26%，预计到2030年将达到39.7亿美元。

大鼠和小鼠模型市场在生物医学研究中发挥重要作用，由于这些囓齿动物与人类之间的遗传和生物学相似性，为人类疾病机制提供了宝贵的见解。这些模型对于研究疾病进展、药物交互作用和基因表现至关重要，对于製药和生物技术产业的临床前测试也至关重要。应用范围涵盖肿瘤学、心臟病学、神经科学、免疫学和遗传学研究，最终用户包括研究机构、製药公司和受託研究机构。目前，市场成长的推动因素包括基因工程技术的进步、研发投资的增加以及需要创新治疗方法的慢性疾病数量的增加。个人化医疗存在发展机会，客製化小鼠模型可以加速标靶治疗的发展。此外，CRISPR-Cas9技术的兴起和基因转殖人源化小鼠模型的广泛使用将扩大研究能力并提供利润丰厚的成长途径。然而，市场扩张受到动物测试、监管挑战以及替代体外和电脑模型转变等伦理问题的限制。维持活体动物群体的复杂性和成本也是一个主要限制。为了利用这些机会，相关人员应专注于人工智慧和机器学习的结合，以提高动物研究资料分析的有效性。强大的试管内模拟技术的发展可以补充并有可能取代传统的动物模型，确保与不断变化的监管和道德标准保持一致。创新也应着重于改进基因操作程序，以提高模型的准确性和相关性。虽然大鼠和小鼠模型市场目前受益于稳定的需求前景，但由于技术进步和不断变化的道德观点，它面临着充满活力的未来，需要该领域的参与者采取适应性策略。随着不断的创新和策略调整，这个市场具有巨大的成长潜力。

主要市场统计
基准年[2023] 22.7亿美元
预计年份 [2024] 24.5亿美元
预测年份 [2030] 39.7亿美元
复合年增长率（%） 8.26%

市场动态：快速发展的大鼠和小鼠模型市场的关键市场洞察

供需的动态交互作用正在改变老鼠模型市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对基因工程模型检验治疗标靶的庞大需求
    • 医药和生技领域研发费用增加
    • 个人化医疗需求快速成长
  • 市场限制因素
    • 大鼠和小鼠模型的伦理问题和局限性
  • 市场机会
    • 倾向于人源化大鼠/小鼠模型
    • 不断发展的治疗研究领域
  • 市场挑战
    • 存在替代测试方法

波特的五力：驾驭大鼠和小鼠模型市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解大鼠和小鼠模型市场的外部影响

外部宏观环境因素在塑造大鼠和小鼠模型市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解大鼠/小鼠模型市场的竞争状况

对大鼠和小鼠模型市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵大鼠模型市场供应商绩效评估

FPNV定位矩阵是评估大鼠和小鼠模型市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以绘製大鼠和小鼠模型市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对大鼠和小鼠模型市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对基因工程模型检验治疗标靶的庞大需求
      • 增加製药和生技领域研发活动的支出
      • 个人化医疗需求快速成长
    • 抑制因素
      • 大鼠和小鼠模型的伦理问题和局限性
    • 机会
      • 致力于具有人性化的主题
      • 不断发展的治疗研究领域
    • 任务
      • 替代测试方法的存在
  • 市场区隔分析
    • 模型类型：基因转殖大鼠提供遗传功能和遗传疾病发展的重要见解
    • 服务：由于需要产生特定的遗传背景，扩大了大鼠和小鼠模型在育种服务中的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依模型类型分類的大鼠和小鼠模型市场

  • 透过调节或手术改造的大鼠
  • 基因改造老鼠
  • 杂交或同类大鼠
  • 免疫力缺乏大鼠
  • 近交系大鼠
  • 近交系大鼠

第七章大鼠和小鼠模型市场：依技术分类

  • 更脆
  • 胚胎干细胞注射
  • 显微注射
  • 核转移

第八章大鼠模型市场：依服务分类

  • 选育
  • 冷冻保存
  • 基因检测
  • 引入授权的模型
  • 隔离
  • 衍生

第 9 章按治疗领域分類的大鼠和小鼠模型市场

  • 心血管疾病
  • 糖尿病
  • 免疫学和炎症
  • 神经病学
  • 肿瘤学
  • 毒理学

第 10 章 大鼠和小鼠模型市场：依最终使用者分类

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第十一章 北美和南美大鼠模型市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区大鼠模型市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲大鼠模型市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Charles River 实验室利用先进的基因工程小鼠模型为临床前研究提供支持
    • 创新的小鼠模式为慢性淋巴性白血病和里氏转化的新治疗方法铺平了道路
    • 发展小鼠模型来阐明 IL-6 在虚弱和老化中的作用
  • 战略分析和建议

公司名单

  • Allentown, Inc.
  • Aragen Life Sciences
  • Biocytogen
  • Biomere Biomedical Research Models, Inc.
  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc. by JSR Corp.
  • Cyagen US Inc.
  • Envigo by Inotiv, Inc.
  • GemPharmatech
  • GenOway SA
  • Harbour Biomed
  • Hera BioLabs
  • Ingenious Targeting Laboratory
  • Janvier Labs
  • Oncodesign Precision Medicine
  • Ozgene Pty Ltd.
  • PerkinElmer, Inc.
  • Pharmatest Services Oy
  • PolyGene AG
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • TransCure Bioservices
  • TransViragen, Inc.
  • Vivo Bio Tech Ltd.
Product Code: MRR-3A2E844FF329

The Rat & Mouse Model Market was valued at USD 2.27 billion in 2023, expected to reach USD 2.45 billion in 2024, and is projected to grow at a CAGR of 8.26%, to USD 3.97 billion by 2030.

The rat and mouse model market serves a crucial role in biomedical research, offering a valuable insight into human disease mechanisms due to genetic and biological similarities between these rodents and humans. These models are essential for studying disease progression, drug interactions, and genetic expressions, thus a necessity in preclinical trials for pharmaceuticals and biotechnology industries. The application scope spans across oncology, cardiology, neuroscience, immunology, and genetic research, with end-users including research institutions, pharmaceutical companies, and contract research organizations. Currently, market growth is propelled by advancements in genetic engineering technologies, rising R&D investments, and an increasing prevalence of chronic diseases necessitating innovative therapeutics. Opportunities lie in personalized medicine, where customized mouse models can accelerate the development of targeted therapies. Additionally, the rise of CRISPR-Cas9 technology and expanded use of humanized mouse models through genetic modification broaden research capabilities, offering lucrative growth avenues. However, market expansion is constrained by ethical concerns regarding animal testing, regulatory challenges, and the transition towards alternative in vitro and in silico models. The complexity and cost associated with maintaining live animal colonies are also significant limitations. To capitalize on these opportunities, stakeholders should focus on integrating AI and machine learning to enhance data analysis efficacy from animal studies. Developing robust in vitro simulation techniques can complement and potentially replace traditional animal models, ensuring alignment with changing regulatory and ethical standards. Innovation should also focus on refining genetic manipulation procedures to improve model accuracy and relevance. While currently benefitting from a robust demand outlook, the rat and mouse model market faces a dynamic future, driven by technological advancements and shifting ethical perspectives, demanding adaptive strategies from players in the sector. Through continuous innovation and strategic adaptation, the market promises significant growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 2.27 billion
Estimated Year [2024] USD 2.45 billion
Forecast Year [2030] USD 3.97 billion
CAGR (%) 8.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Rat & Mouse Model Market

The Rat & Mouse Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant demand for genetically modified models to validate therapeutic targets
    • Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
    • Surge in demand for personalized medicine
  • Market Restraints
    • Ethical concerns and limitation of rat & mouse model
  • Market Opportunities
    • Inclination towards humanized rat & mouse model
    • Growing therapeutic research areas
  • Market Challenges
    • Presence of alternative testing methods

Porter's Five Forces: A Strategic Tool for Navigating the Rat & Mouse Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Rat & Mouse Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Rat & Mouse Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Rat & Mouse Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Rat & Mouse Model Market

A detailed market share analysis in the Rat & Mouse Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Rat & Mouse Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Rat & Mouse Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Rat & Mouse Model Market

A strategic analysis of the Rat & Mouse Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Rat & Mouse Model Market, highlighting leading vendors and their innovative profiles. These include Allentown, Inc., Aragen Life Sciences, Biocytogen, Biomere Biomedical Research Models, Inc., Champions Oncology, Inc., Charles River Laboratories International, Inc., Crown Bioscience, Inc. by JSR Corp., Cyagen US Inc., Envigo by Inotiv, Inc., GemPharmatech, GenOway S.A., Harbour Biomed, Hera BioLabs, Ingenious Targeting Laboratory, Janvier Labs, Oncodesign Precision Medicine, Ozgene Pty Ltd., PerkinElmer, Inc., Pharmatest Services Oy, PolyGene AG, Taconic Biosciences, Inc., The Jackson Laboratory, TransCure Bioservices, TransViragen, Inc., and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Rat & Mouse Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Model Type, market is studied across Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats, Immunodeficient Rats, Inbred Rats, and Outbred Rats.
  • Based on Technology, market is studied across CRISPR, Embryonic Stem Cell Injection, Microinjection, and Nuclear Transfer.
  • Based on Service, market is studied across Breeding, Cryopreservation, Genetic Testing, Model-in-Licensing, Quarantine, and Rederivation.
  • Based on Therapeutic Area, market is studied across Cardiovascular Disease, Diabetes, Immunology & Inflammation, Neurology, Oncology, and Toxicology.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant demand for genetically modified models to validate therapeutic targets
      • 5.1.1.2. Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
      • 5.1.1.3. Surge in demand for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical concerns and limitation of rat & mouse model
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination towards humanized rat & mouse model
      • 5.1.3.2. Growing therapeutic research areas
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative testing methods
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Model Type: Significant critical insights provided by genetically modified rats into genetic functions and pathogenesis of genetic diseases
    • 5.2.2. Service: Expanding usage of rat and mouse models for breeding services due to the necessity to produce specific genetic backgrounds
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Rat & Mouse Model Market, by Model Type

  • 6.1. Introduction
  • 6.2. Conditioned or Surgically Modified Rats
  • 6.3. Genetically Modified Rats
  • 6.4. Hybrid or Congenic Rats
  • 6.5. Immunodeficient Rats
  • 6.6. Inbred Rats
  • 6.7. Outbred Rats

7. Rat & Mouse Model Market, by Technology

  • 7.1. Introduction
  • 7.2. CRISPR
  • 7.3. Embryonic Stem Cell Injection
  • 7.4. Microinjection
  • 7.5. Nuclear Transfer

8. Rat & Mouse Model Market, by Service

  • 8.1. Introduction
  • 8.2. Breeding
  • 8.3. Cryopreservation
  • 8.4. Genetic Testing
  • 8.5. Model-in-Licensing
  • 8.6. Quarantine
  • 8.7. Rederivation

9. Rat & Mouse Model Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Disease
  • 9.3. Diabetes
  • 9.4. Immunology & Inflammation
  • 9.5. Neurology
  • 9.6. Oncology
  • 9.7. Toxicology

10. Rat & Mouse Model Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Rat & Mouse Model Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Rat & Mouse Model Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Rat & Mouse Model Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Enhancing Preclinical Research through Advanced Genetically Modified Mouse Models by Charles River Laboratories
    • 14.3.2. Innovative Mouse Model Paves Way for New Therapies in Chronic Lymphocytic Leukaemia and Richter Transformation
    • 14.3.3. Pioneering a Mouse Model to Elucidate the Role of IL-6 in Frailty and Aging
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allentown, Inc.
  • 2. Aragen Life Sciences
  • 3. Biocytogen
  • 4. Biomere Biomedical Research Models, Inc.
  • 5. Champions Oncology, Inc.
  • 6. Charles River Laboratories International, Inc.
  • 7. Crown Bioscience, Inc. by JSR Corp.
  • 8. Cyagen US Inc.
  • 9. Envigo by Inotiv, Inc.
  • 10. GemPharmatech
  • 11. GenOway S.A.
  • 12. Harbour Biomed
  • 13. Hera BioLabs
  • 14. Ingenious Targeting Laboratory
  • 15. Janvier Labs
  • 16. Oncodesign Precision Medicine
  • 17. Ozgene Pty Ltd.
  • 18. PerkinElmer, Inc.
  • 19. Pharmatest Services Oy
  • 20. PolyGene AG
  • 21. Taconic Biosciences, Inc.
  • 22. The Jackson Laboratory
  • 23. TransCure Bioservices
  • 24. TransViragen, Inc.
  • 25. Vivo Bio Tech Ltd.

LIST OF FIGURES

  • FIGURE 1. RAT & MOUSE MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. RAT & MOUSE MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RAT & MOUSE MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RAT & MOUSE MODEL MARKET DYNAMICS
  • TABLE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONDITIONED OR SURGICALLY MODIFIED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETICALLY MODIFIED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY HYBRID OR CONGENIC RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNODEFICIENT RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INBRED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY OUTBRED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BREEDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL-IN-LICENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY QUARANTINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REDERIVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 129. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 134. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 150. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 155. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 165. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 170. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 175. ITALY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 190. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 195. POLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 200. QATAR RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 205. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 210. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 220. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 225. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 230. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 247. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023